AG Mednet Videos and podcasts
-
Continue To Choose New AI-Related Projects
3/12/2026
After seeing AI reduce setup time and change requests, Novo Nordisk’s Ibrahim Kamstrup-Akkaoui and his team expanded AI’s use to automate documentation and medical coding, allowing staff to focus on complex work while improving efficiency and quality.
-
3 Pillars Of Trustworthy AI In Clinical Trials
3/12/2026
Donna Rivera of Canal Row Advisors stresses that successful and regulator-trusted AI depends on three fundamentals: high-quality, fit-for-purpose data; transparent and explainable models; and cross-disciplinary collaboration to ensure meaningful clinical impact.
-
Start With The Question, Not The Technology
3/12/2026
As a former FDA employee, Donna Rivera emphasizes defining the problem and regulatory context first to ensure any AI solution is fit for purpose.
-
How To Separate AI Hype From Real Value
3/12/2026
Victoria Gamerman, strategy leader for RWD Insights, outlines three principles for evaluating AI solutions, including proven experience, data readiness, and lifecycle ownership.
-
Think Big, Start Small With AI
3/12/2026
Ibrahim Kamstrup-Akkaoui discusses using AI to simulate trials and uncover patterns or new indications to inform smarter study design.
-
What "AI-Ready Data" Really Looks Like
3/12/2026
Of course, “AI ready” is subjective. But, consultant Victoria Gamerman explains that AI readiness requires traceable patient journeys, standardized data definitions, and governance structures.